Search Results - "Pozsgai, E."

β-Sarcoglycan gene transfer decreases fibrosis and restores force in LGMD2E mice by Pozsgai, E R, Griffin, D A, Heller, K N, Mendell, J R, Rodino-Klapac, L R

“…Limb-girdle muscular dystrophy type 2E (LGMD2E) results from mutations in the β-sarcoglycan (SGCB) gene causing loss of functional protein and concomitant loss…”
Get full text

TIP47 protects mitochondrial membrane integrity and inhibits oxidative-stress-induced cell death by Hocsak, E., Racz, B., Szabo, A., Mester, L., Rapolti, E., Pozsgai, E., Javor, Sz, Bellyei, Sz, Gallyas, F., Sumegi, B., Szigeti, A.

“…We found that overexpression of tail interacting protein of 47kDa (TIP47), but not its truncated form (t-TIP47) protected NIH3T3 cells from…”
Get full text

The inhibitory effect of a novel cytotoxic somatostatin analogue AN-162 on experimental glioblastoma by Pozsgai, E, Schally, A V, Halmos, G, Rick, F, Bellyei, S

“…Glioblastoma multiforme is the most common and most aggressive type of high grade tumor with a poor prognosis upon discovery. Based on earlier promising…”
Get more information

G.P.289 by Griffin, D, Pozsgai, E, Johnson, R, Grose, W, Heller, K, Mendell, J.R, Sahenk, Z, Rodino-Klapac, L.R

“…Limb girdle muscular dystrophy type 2L (LGMD2L) is caused by mutations in the anoctamin 5 (ANO5) gene. ANO5 encodes a predicted 107 kDa protein containing 8…”
Get full text

Correlation between Tumor-associated Proteins and Response to Neoadjuvant Treatment in Patients with Advanced Squamous-cell Esophageal Cancer by FARKAS, R, POZSGAI, E, BELLYEI, Sz, CSEKE, L, SZIGETI, A, VERECZKEI, A, MARTON, S, MANGEL, L, HORVATH, O. P, PAPP, A

“…Possible predictive markers of response to neoadjuvant radiochemotherapy (NRCT) of esophageal cancer have been identified. Patient biopsies were obtained from…”
Get full text

Inhibition of growth of HEC-1-A and HEC-1-B human endometrial cancer by growth hormone releasing hormone antagonist JMR-132 by Papadia, A, Andrew, S, Seitz, S, Stefan, B, Szalontay, L, Rick, F, Halmos, G, Bellyei, S, Pozsgai, E, Lucci, J

Get full text

The effect of carotid stenting on rheological parameters, free radical production and platelet aggregation by Szapary, L, Bagoly, E, Kover, F, Feher, G, Pozsgai, E, Koltai, K, Hanto, K, Komoly, S, Doczi, T, Toth, K

“…Carotid artery stenting has become a possible treatment of significant carotid stenosis. The risk of stent occlusion and restenosis might be increased by…”
Get more information

LIMB GIRDLE MUSCULAR DYSTROPHIES by Pozsgai, E., Peterson, E., Kempton, A., Rogers, O., Seo, Y., Rodino-Klapac, L.

Get full text

LIMB GIRDLE MUSCULAR DYSTROPHIES: P.137 Treatment of aged mice and long-term durability of AAV-mediated gene therapy in two mouse models of Limb girdle muscular dystrophy by Pozsgai, E., Griffin, D., Peterson, E., Kempton, A., Rogers, O., Seo, Y., Rodino-Klapac, L.

Get full text

LIMB GIRDLE MUSCULAR DYSTROPHIES by Pozsgai, E., Griffin, D., Peterson, E., Kempton, A., Rogers, O., Seo, Y., Rodino-Klapac, L.

Get full text

LIMB GIRDLE MUSCULAR DYSTROPHIES: P.139 Expression-functional correlation and validation of a surrogate marker for DAPC restoration in LGMD2E mouse model by Pozsgai, E., Peterson, E., Kempton, A., Rogers, O., Seo, Y., Rodino-Klapac, L.

Get full text

Prognostic role of HPV infection in esophageal squamous cell carcinoma by Bognar, L., Bellyei, S., Hegedus, I., Gombos, K., Horvath, O.P., Vereczkei, A., Pozsgai, E., Papp, A.

Get full text

P.134a Phase 1/2a trial of delandistrogene moxeparvovec in patients with DMD: 4-year update by Mendell, J., Sahenk, Z., Lehman, K., Lowes, L., Reash, N., Iammarino, M., Alfano, L., Lewis, S., Church, K., Shell, R., Potter, R., Griffin, D., Pozsgai, E., Hogan, M., Hu, L., Mason, S., Darton, E., Rodino-Klapac, L.

Get full text

P.170 Safety, β-sarcoglycan expression, and functional outcomes from systemic gene transfer of bidridistrogene xeboparvovec in limb-girdle muscular dystrophy type 2E/R4 by Rodino-Klapac, L., Pozsgai, E., Lewis, S., Griffin, D., Meadows, A., Lehman, K., Church, K., Reash, N., Iammarino, M., Sabo, B., Alfano, L., Lowes, L., Neuhaus, S., Li, X., Mendell, J.

Get full text

LIMB GIRDLE MUSCULAR DYSTROPHIES by Seo, Y., Kempton, A., Rogers, O., Baine, S., Lewis, S., Adegboye, K., Haile, A., Griffin, D., Peterson, E., Pozsgai, E., Rodino-Klapac, L.

Get full text

LIMB GIRDLE MUSCULAR DYSTROPHIES: P.140 Systemic gene transfer with rAAVrh74.MHCK7.SGCB increased Beta-sarcoglycan expression in patients with Limb girdle muscular dystrophy type 2E (LGMD2E) by Rodino-Klapac, L., Pozsgai, E., Lewis, S., Griffin, D., Meadows, A., Lehman, K., Church, K., Miller, N., Iammarino, M., Lowes, L., Mendell, J.

Get full text

LIMB GIRDLE MUSCULAR DYSTROPHIES by Rodino-Klapac, L., Pozsgai, E., Lewis, S., Griffin, D., Meadows, A., Lehman, K., Church, K., Miller, N., Iammarino, M., Lowes, L., Mendell, J.

Get full text

LIMB GIRDLE MUSCULAR DYSTROPHIES: P.138 Systemic dose-finding study with AAV-Mediated gamma-sarcoglycan gene therapy for treatment of muscle deficits in LGMD2C Mice by Seo, Y., Kempton, A., Rogers, O., Baine, S., Lewis, S., Adegboye, K., Haile, A., Griffin, D., Peterson, E., Pozsgai, E., Rodino-Klapac, L.

Get full text

DMD - TREATMENT: EP.139 Phase 1/2a trial of SRP-9001 in patients with Duchenne muscular dystrophy: 3-year safety and functional outcomes by Mendell, J., Sahenk, Z., Lehman, K., Nease, C., Lowes, L., Reash, N., Iammarino, M., Alfano, L., Vaiea, J., Lewis, S., Church, K., Shell, R., Potter, R., Griffin, D., Pozsgai, E., Hogan, M., Rodino-Klapac, L.

Get full text

DMD - TREATMENT by Mendell, J., Sahenk, Z., Lehman, K., Nease, C., Lowes, L., Reash, N., Iammarino, M., Alfano, L., Vaiea, J., Lewis, S., Church, K., Shell, R., Potter, R., Griffin, D., Pozsgai, E., Hogan, M., Rodino-Klapac, L.

Get full text